http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003113790-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-53 |
| filingDate | 2003-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b9cad0b3f056a971a38e98bec665b98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d0f6da2d10b6cd1bfd5d5dc82e76eb5 |
| publicationDate | 2003-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003113790-A1 |
| titleOfInvention | 26343, a novel human oxidoreductase and uses therefor |
| abstract | The invention provides isolated nucleic acids molecules, designated OP nucleic acid molecules, which encode a novel family of oxidoreductase proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing OP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an OP gene has been introduced or disrupted. The invention still further provides isolated OP proteins, fusion proteins, antigenic peptides, and anti-OP antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
| priorityDate | 2000-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1907.